You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Goserelin

Showing 1 - 25 of 340
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Goserelin
  • +3 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Premature Ovarian Failure Trial in Fayoum (Goserelin, Chemotherapy)

Enrolling by invitation
  • Premature Ovarian Failure
  • Fayoum, Mesala, Egypt
    Beni Suef university
Dec 8, 2022

Advanced Prostate Cancer Trial in Visakhapatnam (Inj. Goserelin (Test) Subcutaneously, Inj. Zoladex (Reference) Subcutaneously)

Recruiting
  • Advanced Prostate Cancer
  • Inj. Goserelin (Test) Subcutaneously
  • Inj. Zoladex (Reference) Subcutaneously
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022

Breast Cancer Trial in Visakhapatnam (Goserelin acetate 3.6 mg Injection, ZOLADEX® 3.6mg Injection)

Recruiting
  • Breast Cancer
  • Goserelin acetate 3.6 mg Injection
  • ZOLADEX® 3.6mg Injection
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c, Letrozole or anastrozole, Goserelin acetate
  • Placebo, Letrozole or anastrozole, Goserelin acetate
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jul 4, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c,Fulvestrant,Goserelin acetate
  • Placebo,Fulvestrant,Goserelin acetate
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 30, 2022

Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Phoenix, Arizona
  • +3 more
Jan 30, 2023

Prostate Cancer Trial in Guangzhou (Goserelin Acetate Sustained-Release Microspheres for Injection, Zoladex 10.8 MG Drug

Not yet recruiting
  • Prostate Cancer
  • Goserelin Acetate Sustained-Release Microspheres for Injection
  • Zoladex 10.8 MG Drug Implant
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
May 3, 2023

Breast Tumors Trial (Chidamide combined with exemestane (+/- goserelin), Chemotherapy with docetaxel plus epirubicin or change

Not yet recruiting
  • Breast Neoplasms
  • Chidamide combined with exemestane (+/- goserelin)
  • Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)
  • (no location specified)
Feb 15, 2022

Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

Recruiting
  • Breast Cancer
  • Tianjin, Tianjin, China
    Jie Ge
Aug 20, 2023

Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Docetaxel / Capecitabine
  • +5 more
  • Cairo, Egypt
  • +51 more
Oct 24, 2022

Breast Cancer Trial in Hangzhou (LY01005, ZOLADEX® 3.6 mg)

Recruiting
  • Breast Cancer
  • Hangzhou, China
    Zhejiang Cancer Hospital
Nov 3, 2021

Prostate Cancer Trial in Guangzhou (LY01005, ZOLADEX® 3.6 mg)

Active, not recruiting
  • Prostate Cancer
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 19, 2021

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,

Completed
  • Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
  • Hong Kong, Hong Kong
  • +14 more
Oct 25, 2022

Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

Not yet recruiting
  • Early Breast Cancer
  • (no location specified)
Apr 12, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Prostate Cancer Trial in Denver, Dallas, San Antonio (Ozarelix, Goserelin)

Completed
  • Prostate Cancer
  • Denver, Colorado
  • +2 more
Sep 30, 2021

Prostate Cancer Trial in Shanghai (LY01005 3.6 mg, ZOLADEX® 3.6 mg)

Completed
  • Prostate Cancer
  • LY01005 3.6 mg
  • ZOLADEX® 3.6 mg
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 20, 2021

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Breast Tumors Trial in Shijiazhuang (FCN-437c+Fulvestrant, FCN-437c+Letrozole+Goserelin)

Recruiting
  • Breast Neoplasms
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 5, 2021

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022